| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $18.1M | -53.5% |
| R&D Expense | $73.7M | -12.7% |
| SG&A Expense | $22.5M | +26.0% |
| Operating Income | -$78.1M | -19.3% |
| Interest Expense | $459K | -73.4% |
| Income Tax | $0 | -100.0% |
| Net Income | -$72.8M | -4.9% |
| EPS (Basic) | -$0.44 | +4.3% |
| EPS (Diluted) | -$0.44 |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $26.3M | -14.6% |
| Short-term Investments | $99.7M | -14.1% |
| Accounts Receivable | $1.8M | +31.4% |
| Current Assets | $132.0M | -12.6% |
| Total Assets | $144.4M | -26.1% |
| Current Liabilities | $22.5M | -31.6% |
| Long-term Debt | $0 | — |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$85.9M | -143.1% |
| Capital Expenditures | $1.0M | +96.9% |
| Investing Cash Flow | $50.8M | +167.7% |
| Financing Cash Flow | $30.6M | -3.7% |
| Free Cash Flow | -$86.9M | -142.4% |
| +4.3% |
| Total Liabilities |
| $38.4M |
| -34.5% |
| Stockholders' Equity | $106.0M | -22.5% |